Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 5/2007

01-10-2007

How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?

Authors: Peter E. H. Schwarz, Jiang Li, Jaana Lindström, Antje Bergmann, Ulrike Gruhl, Timo Saaristo, Jaakko Tuomilehto

Published in: Current Diabetes Reports | Issue 5/2007

Login to get access
Metadata
Title
How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?
Authors
Peter E. H. Schwarz
Jiang Li
Jaana Lindström
Antje Bergmann
Ulrike Gruhl
Timo Saaristo
Jaakko Tuomilehto
Publication date
01-10-2007
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 5/2007
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-007-0058-7

Other articles of this Issue 5/2007

Current Diabetes Reports 5/2007 Go to the issue

OriginalPaper

The use of motivational interviewing in weight loss

OriginalPaper

Cultural approaches to diabetes self-management programs for the Latino community

OriginalPaper

Exenatide and rimonabant: New treatments that may be useful in the management of diabetes and obesity

Clinical Trials Report

The TODAY study

OriginalPaper

Who should benefit from the use of alpha-glucosidase inhibitors?

OriginalPaper

Web alert
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits